Juncture Wealth Strategies’s Globus Medical GMED Stock Holding History

Juncture Wealth Strategies’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$845K	Buy	10,692 +1,166	+12%	+$99.1K	0.22%	72
2026 Q1	$821K	Buy	9,526 +506	+6%	+$45.4K	0.27%	58
2025 Q4	$788K	Buy	9,020 +399	+5%	+$30.3K	0.26%	55
2025 Q3	$494K	Buy	8,621 +1,300	+18%	+$74.9K	0.17%	72
2025 Q2	$432K	Sell	7,321 -2,980	-29%	-$193K	0.15%	79
2025 Q1	$754K	Sell	10,301 -439	-4%	-$36.3K	0.29%	59
2024 Q4	$888K	Buy	10,740 +69	+0.6%	+$5.44K	0.33%	48
2024 Q3	$763K	Buy	10,671 +265	+3%	+$18.7K	0.3%	52
2024 Q2	$713K	Buy	10,406 +3,648	+54%	+$218K	0.3%	53
2024 Q1	$362K	Buy	+6,758	New	+$363K	0.16%	80

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Juncture Wealth Strategies's GMED Position: Q2 2026 in Review

Juncture Wealth Strategies increased its Globus Medical (GMED) stake by 12% in Q2 2026, buying an estimated $99.1K and bringing the position to 10,692 shares worth $845K. The position accounts for 0.22% of the portfolio, ranked #72.

Juncture Wealth Strategies first reported a position in GMED in Q1 2024 and has held it in 10 quarters since. The position peaked at $888K in Q4 2024. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Juncture Wealth Strategies held 10,692 shares of Globus Medical worth $845K as of Q2 2026.
Juncture Wealth Strategies bought 1,166 Globus Medical shares in Q2 2026, an estimated $99.1K.
Globus Medical made up 0.22% of Juncture Wealth Strategies's portfolio in Q2 2026, its #72 holding.
Juncture Wealth Strategies first reported a position in Globus Medical in Q1 2024 and has held it in 10 quarters since.
Juncture Wealth Strategies's Globus Medical position peaked at $888K in Q4 2024.
599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Juncture Wealth Strategies's 13F filing for Q2 2026, filed 9 Jul 2026.